N4D Therapeutics provides breathable therapeutic formulations capable of targeting and treating the diseased heart: no such a treatment is available today. The innovation potential of N4D Therapeutics is expected to challenge the currently available treatment & care strategies for heart failure patients by providing a therapeutic solution that combine recent advances in the nanomedicine technology field, non-intrusive lung-to-heart delivery, and innovative active principle. The proposed inhalation route, which is expected to provide to the heart an important concentration of API impossible to obtain by systemic intravenous administration, offers a “patient friendly” approach and will alleviate the physical and emotional burden on those patients treated with drugs by injection and/or any other minimally though invasive procedures facilitating patient compliance....
N4D Therapeutics provides breathable therapeutic formulations capable of targeting and treating the diseased heart: no such a treatment is available today. The innovation potential of N4D Therapeutics is expected to challenge the currently available treatment & care strategies for heart failure patients by providing a therapeutic solution that combine recent advances in the nanomedicine technology field, non-intrusive lung-to-heart delivery, and innovative active principle. The proposed inhalation route, which is expected to provide to the heart an important concentration of API impossible to obtain by systemic intravenous administration, offers a “patient friendly” approach and will alleviate the physical and emotional burden on those patients treated with drugs by injection and/or any other minimally though invasive procedures facilitating patient compliance.
More information

Investors

Health&Biotech Accelerator
Admin
Health&Biotech Accelerator #WeDisruptLifeSciencesSystem

Advisors

Alessandro Faragli
Admin
Alessandro Faragli Cardiologist, Entrepreneur